Critiques of the ACA: Legislative Challenges and Rising Premiums
Discover the challenges facing the ACA as rising premiums and legislative hurdles prompt debate over its future and the implications for consumers.
Discover the challenges facing the ACA as rising premiums and legislative hurdles prompt debate over its future and the implications for consumers.
CMS proposes new payment structures for outpatient services under Medicare, impacting provider compliance and drug pricing, inviting stakeholder feedback by Aug 31, 2026.
CMS proposes to cut 340B drug reimbursement rates for 2027, seeking to align payments with actual acquisition costs and reduce expenditures by $5.7 billion.
Discover critical 2026 regulatory changes by CMS and FDA that will impact reimbursement, prescribing practices, and patient care throughout healthcare specialties.
Explore how federal budget cuts affect cancer research funding and the implications for health insurance coverage options amid rising treatment costs.
The surge in Medicare claims linked to transplants highlights significant fraud risks, prompting strict enforcement measures by the government to protect patients.
Explore insights on medical debt in Virginia and potential policy solutions from the Schroeder Center's latest research.
Explore the rise in Medicare Advantage denials and upcoming regulatory changes aimed at improving patient rights and healthcare access for seniors.
New Medicare initiative reduces copayments for GLP-1 medications, enhancing affordability and potentially lowering overall healthcare costs for beneficiaries.
Vermont's new Executive Order addresses high insurance costs and improves healthcare affordability through regulatory reform and legislative collaboration.